Mercer Global Advisors
CSBR icon

Mercer Global Advisors’s Champions Oncology CSBR Stock Holding History

Mercer Global Advisors’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.7K Buy
+12,775
New +$77K ﹤0.01% 4014

Other funds holding CSBR

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Mercer Global Advisors's CSBR Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Champions Oncology (CSBR) in Q2 2026: 12,775 shares worth $78.7K. The stake represents ﹤0.01% of the portfolio and ranks #4014 among its holdings.

23 funds tracked by Wall St. Rank hold CSBR as of Q2 2026.

  • Mercer Global Advisors held 12,775 shares of Champions Oncology worth $78.7K as of Q2 2026.
  • Champions Oncology was a new Mercer Global Advisors position in Q2 2026.
  • Champions Oncology made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4014 holding.
  • 23 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.